Max India Limited , a key player in the Max Group's Senior Care business, has scheduled an earnings conference call to discuss its Q2 and H1 FY26 financial results. The call is set for Friday, November 14, 2025, at 11:00 AM IST, as announced in a recent corporate filing.

Conference Call Details

The virtual conference call will be open to all investors and the general public. Senior management teams from Max India and Antara, its senior care subsidiary, will participate in the call to provide insights into the company's performance and future outlook.

Company Overview

Max India Limited serves as the holding company for Max Group's Senior Care business, which includes Antara Senior Living Limited and Antara Assisted Care Services Limited. The company is part of the larger Max Group, a leading Indian multi-business conglomerate with a strong presence in the Life Insurance industry and ventures in Senior Care and Real Estate.

Key Financial Highlights

For the fiscal year 2025, the Max Group reported:

Antara's Growth Plans

Antara, a key subsidiary of Max India, has ambitious plans for expansion in the senior care sector:

• Develop 8-10 residential communities for seniors
• Build a bed capacity of ~2,000 beds in Care Homes over the next 5 years
• Currently operates 340+ beds across Delhi NCR, Bengaluru, and Chennai
• Plans to increase bed capacity to ~500 beds by Q3FY26

Investor Information

The earnings call presents an opportunity for investors to gain insights into Max India's financial performance and strategic direction. Interested parties can access the call through various local access numbers provided for different countries, including India, Hong Kong, Singapore, UK, and USA.

As Max India continues to strengthen its position in the senior care market, this earnings call will be crucial for stakeholders to understand the company's progress and future prospects in this growing sector.

Max India Limited, a prominent player in the Indian healthcare and allied sectors, has successfully raised ₹80.35 crore through a preferential issue of convertible warrants. The company's Board of Directors approved the allotment of 36,19,594 fully convertible warrants at ₹222 per warrant on September 24, 2025.

Warrant Allotment Details

The allotment includes both promoter and non-promoter entities, with the following breakdown:

Key Points of the Preferential Issue

• Total Warrants Issued: 36,19,594
• Issue Price: ₹222 per warrant
• Total Amount Raised: ₹80,35,49,868

Warrant Conversion and Lock-in Period

Each warrant is convertible into one fully paid-up equity share of ₹10 upon payment of the remaining 50% consideration. The allotted securities are subject to lock-in restrictions as per the Securities and Exchange Board of India (SEBI) regulations.

Initial Payment and Future Conversion

Max India has received 50% of the total consideration, amounting to ₹40,17,74,934, at the time of allotment. The balance 50% will be payable upon conversion of the warrants into equity shares.

Regulatory Compliance

The preferential issue was conducted in accordance with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. The company has duly informed the BSE Limited and the National Stock Exchange of India Limited about the allotment.

This strategic move by Max India Limited is expected to strengthen its financial position and support its growth initiatives in the healthcare sector. The participation of both promoter and non-promoter entities in this preferential issue demonstrates confidence in the company's future prospects.